Category: Press Release - Psychedelic Alpha

Our 2022 Year in Review is now live.

Read more about the article Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023

Numinus Announces Four Peer-Reviewed Publications from its Chief Clinical Officer in 2023

Post published:March 21, 2023
Post category:Press Release

Read more about the article Wesana Health Announces Sale of SANA-13 Assets to Lucy Scientific Discovery

Wesana Health Announces Sale of SANA-13 Assets to Lucy Scientific Discovery

Post published:March 21, 2023
Post category:Press Release

Read more about the article Psyence Partners with iNGENū for Palliative Care Clinical Trial in Australia

Psyence Partners with iNGENū for Palliative Care Clinical Trial in Australia

Post published:March 21, 2023
Post category:Press Release

Read more about the article Algernon Pharmaceuticals Announces Launch of Rights Offering

Algernon Pharmaceuticals Announces Launch of Rights Offering

Post published:March 21, 2023
Post category:Press Release

Read more about the article Diamond Therapeutics Announces FDA-authorized Clinical Trial of Low-Dose Psilocybin in Collaboration with University of Alabama at Birmingham

Diamond Therapeutics Announces FDA-authorized Clinical Trial of Low-Dose Psilocybin in Collaboration with University of Alabama at Birmingham

Post published:March 21, 2023
Post category:Press Release

Read more about the article Revive Therapeutics Provides Update of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

Revive Therapeutics Provides Update of Phase 3 Clinical Study for Bucillamine in the Treatment of COVID-19

Post published:March 20, 2023
Post category:Press Release

Read more about the article Clearmind Medicine Submits IND Application to FDA for its Proprietary CMND-100 Treating Alcohol Use Disorder

Clearmind Medicine Submits IND Application to FDA for its Proprietary CMND-100 Treating Alcohol Use Disorder

Post published:March 16, 2023
Post category:Press Release

Read more about the article MYDECINE INNOVATIONS GROUP ANNOUNCES COMMON SHARE SUBSCRIPTION AGREEMENT

MYDECINE INNOVATIONS GROUP ANNOUNCES COMMON SHARE SUBSCRIPTION AGREEMENT

Post published:March 15, 2023
Post category:Press Release

Read more about the article Field Trip Health & Wellness to Close Clinics in 5 Locations

Field Trip Health & Wellness to Close Clinics in 5 Locations

Post published:March 15, 2023
Post category:Press Release

Read more about the article Silo Pharma Announces Positive Results from IND-Enabling Study of SP-26 for Fibromyalgia

Silo Pharma Announces Positive Results from IND-Enabling Study of SP-26 for Fibromyalgia

Post published:March 15, 2023
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.